- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07469020
CLE-PAD : Prevalência de PAD em Pacientes com Estenose Lombar Cirúrgica da Coluna Vertebral (CLE-PAD)
CLE-PAD: Prevalência de Doença Arterial Periférica dos Membros Inferiores em Pacientes com Estenose Lombar Cirúrgica
The goal of this interventional study is to evaluate the rate of existing lower limb peripheral artery disease (PAD) in patients with surgically lumbar spinal stenosis (LSS). PAD and LSS can present similar symptoms and it can be difficult to diagnose PAD using conventional methods, depending on the location of the arterial disease. The main questions it aims to answer are :
- What's the prevalence of PAD in LSS patients?
- Which exam among routine tools is the most accurate to diagnose PAD in this population? Around their surgery for LSS (a few weeks before or after), participants will be included in a vascular medicine service. After checking of eligibility criteria, they will undergo a contrast-enhanced CT scan for the diagnosis of PAD and various routine diagnostic tests: Doppler ultrasound, treadmill tests, pressure index, pulse palpation.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Lumbar spinal stenosis (LSS) is a debilitating degenerative condition in older people associated with lower back pain, pain in the lower limbs and a reduced quality of life. LSS can be treated surgically, but the results are mixed: 35% of patients report low satisfaction one year after surgery. The symptoms of LSC in the lower limbs can mimic those associated with peripheral arterial disease (PAD). The prevalence of PAD in the LSC population varies between 4.1% and 67.8% depending on the diagnostic tests used and the populations studied. Thus, the precise analysis of the prevalence of PAD and the sensitivity and specificity of PAD diagnostic tests in this population remain to be determined. These analyses would help to optimise PAD diagnostic tools, while possibly providing an explanation for the post-operative persistence of functional discomfort in CLE patients. Furthermore, a better understanding of the vascular system in the CLE population offers hope for optimising patient care, both from a medical and a medico-economic point of view.
The experimental visit takes place as soon as possible after receipt of the biological assessment and within a maximum period of 3 months. During this visit, specific research examinations will be performed, including stress tests (stress TcPO2 according to the modified Strandness protocol and stress TcPO2 according to the Gardner-Skinner increasing load protocol), as well as an injected scan of the aorta of the lower limbs. The pseudonymised CT scan will be sent to the sponsor for blind review. A follow-up telephone call will be made between 7 and 10 days after the CT scan to detect the occurrence of any adverse events. The study will then be completed for the participant.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Marie-Laure Gervais
- Número de telefone: +33299284321
- E-mail: marie-laure.gervais@chu-rennes.fr
Locais de estudo
-
-
-
Lille, França
- Ainda não está recrutando
- Groupement des Hôpitaux de l'Institut Catholique de Lille
-
Contato:
- Marjolaine Talbot
- Número de telefone: +33320225000
- E-mail: talbot.marjolaine@ghicl.net
-
Investigador principal:
- Marjolaine Talbot
-
Paris, França
- Recrutamento
- Groupe hospitalier Paris Saint Joseph
-
Contato:
- Ewa Tuleja
- Número de telefone: +33144127137
- E-mail: etuleja@ghpsj.fr
-
Investigador principal:
- Ewa Tuleja
-
Rennes, França
- Recrutamento
- CHU Rennes
-
Contato:
- Marie Charasson
- Número de telefone: +33299284321
- E-mail: marie.charasson@chu-rennes.fr
-
Investigador principal:
- Marie Charasson
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Presenting with a lumbar spinal stenosis with surgical indication, either unoperated or operated on less than 3 months ago
- Affiliated with a social security scheme
- Having received oral and written information about the protocol and having signed a written consent form to participate in this research.
Exclusion Criteria:
-
emergency surgical care
-
Contraindication to contrast enhanced CT scan
- Stroke or myocardial infarction (MI) within the last 3 months
- Known severe or poorly tolerated arrhythmia
- Known severe or symptomatic left ventricular outflow obstruction
- Decompensated heart failure
- History within the last 3 months of venous thromboembolic disease, myopericarditis, endocarditis, aortic dissection or intracardiac thrombus
- Severe uncontrolled hypertension (BP > 200/110 mmHg)
- Inability to walk on the treadmill
- Major lower limb amputation
- Adult subject to legal protection
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Participantes
|
contrast-enhanced CT scan |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Number of patients with PAD identified during the contrast enhanced CT scan
Prazo: 3 months
|
Number of patients with PAD identified during the contrast enhanced CT scan. PAD will be defined by the presence of at least one arterial stenosis ≥ 50% on the arterial axes located from the abdominal aorta to the origin of the tibiofibular arterial trunk, as determined by CT scan of the aorta and lower limbs in accordance with the recommendations. |
3 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Efficiency of diagnosis test "pulse"
Prazo: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "pulse" : the absence of distal pulses will be considered pathological |
3 months
|
|
Efficiency of diagnosis test "systolic pressure index"
Prazo: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "systolic pressure index" : A resting systolic pressure index ≤ 0.90 will be considered pathological in accordance with the recommendations. |
3 months
|
|
Efficiency of diagnosis test "toe systolic pressure index"
Prazo: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "toe systolic pressure index" : A resting toe systolic pressure index ≤ 0.70 will be considered pathological in accordance with the recommendations. |
3 months
|
|
Efficiency of diagnosis test "Aorto-iliac and lower limb Doppler ultrasound"
Prazo: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "Aorto-iliac and lower limb Doppler ultrasound " : velocimetric criteria for stenosis and Saint-Bonnet B and CD, E and 0 Doppler curves considered pathological (i.e. AOMI) in accordance with recommendations . |
3 months
|
|
Efficiency of diagnosis test "exercise oxymetry"
Prazo: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "exercise oxymetry " : Delta from rest oxygen pressure (DROP) ≤ -15 mmHg will be considered pathological (i.e. AOMI) in accordance with the recommendations. . |
3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Marjolaine Talbot, Groupement des Hôpitaux de l'Institut Catholique de Lille
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 35R24_8825_04_CLE-PAD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .